GLP-1 drugs , or glucagon-like peptide-1 analogs , represent a truly shift in how we approach type 2 diabetes . These new therapies help mimicking the body’s own GLP-1 process, which promotes blood https://sirketlist.com/story23522995/glp-1-a-revolutionary-approach-in-blood-sugar-care